Artigo Acesso aberto Revisado por pares

Comprehensive Clinical and Molecular Analysis of 12 Families with Type 1 Recessive Cutis Laxa

2012; Wiley; Volume: 34; Issue: 1 Linguagem: Inglês

10.1002/humu.22165

ISSN

1098-1004

Autores

Bert Callewaert, Chi-Ting Su, Tim Van Damme, Philip Vlummens, Fransiska Malfait, Olivier Vanakker, Bianca Schulz, Meghan Mac Neal, Elaine C. Davis, Joseph G. H. Lee, Aïcha Salhi, Sheila Unger, Ketil Heimdal, Salomé de Almeida, Uwe Kornak, Harald Gaspar, J. Bresson, Katrina Prescott, Maria E. Gosendi, Sahar Mansour, Gérald Pierard, Suneeta Madan‐Khetarpal, Frank C. Sciurba, Sofie Symoens, Paul Coucke, Lionel Van Maldergem, Zsolt Urbán, Anne De Paepe,

Tópico(s)

Congenital limb and hand anomalies

Resumo

Human MutationVolume 34, Issue 1 p. 111-121 Research Article Comprehensive Clinical and Molecular Analysis of 12 Families with Type 1 Recessive Cutis Laxa Bert Callewaert, Corresponding Author Bert Callewaert Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium These two authors contributed equally to this work. Correspondence to: Bert Callewaert, Center for Medical Genetics, Ghent University Hospital, De Pintelaan 185, B-9000 Ghent, Belgium. E-mail: [email protected]Search for more papers by this authorChi-Ting Su, Chi-Ting Su Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania These two authors contributed equally to this work.Search for more papers by this authorTim Van Damme, Tim Van Damme Center for Medical Genetics, Ghent University Hospital, Ghent, BelgiumSearch for more papers by this authorPhilip Vlummens, Philip Vlummens Center for Medical Genetics, Ghent University Hospital, Ghent, BelgiumSearch for more papers by this authorFransiska Malfait, Fransiska Malfait Center for Medical Genetics, Ghent University Hospital, Ghent, BelgiumSearch for more papers by this authorOlivier Vanakker, Olivier Vanakker Center for Medical Genetics, Ghent University Hospital, Ghent, BelgiumSearch for more papers by this authorBianca Schulz, Bianca Schulz Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PennsylvaniaSearch for more papers by this authorMeghan Mac Neal, Meghan Mac Neal Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PennsylvaniaSearch for more papers by this authorElaine C. Davis, Elaine C. Davis Department of Anatomy and Cell Biology, McGill University, Montreal, CanadaSearch for more papers by this authorJoseph G.H. Lee, Joseph G.H. Lee Department of Anatomy and Cell Biology, McGill University, Montreal, CanadaSearch for more papers by this authorAicha Salhi, Aicha Salhi Department of Dermatology, Faculty of Medicine, Alger, AlgeriaSearch for more papers by this authorSheila Unger, Sheila Unger Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois, Lausanne, SwitzerlandSearch for more papers by this authorKetil Heimdal, Ketil Heimdal Department of Medical Genetics, Oslo University Hospital, Olso, NorwaySearch for more papers by this authorSalome De Almeida, Salome De Almeida Department of Medical Genetics, Hospitals Civis De Lisboa, Lisboa, PortugalSearch for more papers by this authorUwe Kornak, Uwe Kornak Charité, Campus Virchow-Klinikum, Berlin, GermanySearch for more papers by this authorHarald Gaspar, Harald Gaspar Institute of Human Genetics, Heidelberg University, Heidelberg, GermanySearch for more papers by this authorJean-Luc Bresson, Jean-Luc Bresson Service de Génétique, CHU Saint-Jacques, Besançon, FranceSearch for more papers by this authorKatrina Prescott, Katrina Prescott Department of Clinical Genetics, Chapel Allerton Hospital, Leeds, UKSearch for more papers by this authorMaria E. Gosendi, Maria E. Gosendi Department of Pediatrics, General Hospital of Llerenda, Badajoz, SpainSearch for more papers by this authorSahar Mansour, Sahar Mansour Department of Clinical genetics, St George's University of London, London, UKSearch for more papers by this authorGérald E. Piérard, Gérald E. Piérard Department of Dermatopathology University Hospital of Liège, Liège, BelgiumSearch for more papers by this authorSuneeta Madan-Khetarpal, Suneeta Madan-Khetarpal Division of Medical Genetics, Department of Pediatrics, Children's Hospital of Pittsburgh, PennsylvaniaSearch for more papers by this authorFrank C. Sciurba, Frank C. Sciurba Division of Pulmonary and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PennsylvaniaSearch for more papers by this authorSofie Symoens, Sofie Symoens Center for Medical Genetics, Ghent University Hospital, Ghent, BelgiumSearch for more papers by this authorPaul J Coucke, Paul J Coucke Center for Medical Genetics, Ghent University Hospital, Ghent, BelgiumSearch for more papers by this authorLionel Van Maldergem, Lionel Van Maldergem Centre de Génétique Humaine, Université de Franche-Comté, Besançon, FranceSearch for more papers by this authorZsolt Urban, Zsolt Urban Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania These two authors contributed equally to this work.Search for more papers by this authorAnne De Paepe, Anne De Paepe Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium These two authors contributed equally to this work.Search for more papers by this author Bert Callewaert, Corresponding Author Bert Callewaert Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium These two authors contributed equally to this work. Correspondence to: Bert Callewaert, Center for Medical Genetics, Ghent University Hospital, De Pintelaan 185, B-9000 Ghent, Belgium. E-mail: [email protected]Search for more papers by this authorChi-Ting Su, Chi-Ting Su Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania These two authors contributed equally to this work.Search for more papers by this authorTim Van Damme, Tim Van Damme Center for Medical Genetics, Ghent University Hospital, Ghent, BelgiumSearch for more papers by this authorPhilip Vlummens, Philip Vlummens Center for Medical Genetics, Ghent University Hospital, Ghent, BelgiumSearch for more papers by this authorFransiska Malfait, Fransiska Malfait Center for Medical Genetics, Ghent University Hospital, Ghent, BelgiumSearch for more papers by this authorOlivier Vanakker, Olivier Vanakker Center for Medical Genetics, Ghent University Hospital, Ghent, BelgiumSearch for more papers by this authorBianca Schulz, Bianca Schulz Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PennsylvaniaSearch for more papers by this authorMeghan Mac Neal, Meghan Mac Neal Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PennsylvaniaSearch for more papers by this authorElaine C. Davis, Elaine C. Davis Department of Anatomy and Cell Biology, McGill University, Montreal, CanadaSearch for more papers by this authorJoseph G.H. Lee, Joseph G.H. Lee Department of Anatomy and Cell Biology, McGill University, Montreal, CanadaSearch for more papers by this authorAicha Salhi, Aicha Salhi Department of Dermatology, Faculty of Medicine, Alger, AlgeriaSearch for more papers by this authorSheila Unger, Sheila Unger Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois, Lausanne, SwitzerlandSearch for more papers by this authorKetil Heimdal, Ketil Heimdal Department of Medical Genetics, Oslo University Hospital, Olso, NorwaySearch for more papers by this authorSalome De Almeida, Salome De Almeida Department of Medical Genetics, Hospitals Civis De Lisboa, Lisboa, PortugalSearch for more papers by this authorUwe Kornak, Uwe Kornak Charité, Campus Virchow-Klinikum, Berlin, GermanySearch for more papers by this authorHarald Gaspar, Harald Gaspar Institute of Human Genetics, Heidelberg University, Heidelberg, GermanySearch for more papers by this authorJean-Luc Bresson, Jean-Luc Bresson Service de Génétique, CHU Saint-Jacques, Besançon, FranceSearch for more papers by this authorKatrina Prescott, Katrina Prescott Department of Clinical Genetics, Chapel Allerton Hospital, Leeds, UKSearch for more papers by this authorMaria E. Gosendi, Maria E. Gosendi Department of Pediatrics, General Hospital of Llerenda, Badajoz, SpainSearch for more papers by this authorSahar Mansour, Sahar Mansour Department of Clinical genetics, St George's University of London, London, UKSearch for more papers by this authorGérald E. Piérard, Gérald E. Piérard Department of Dermatopathology University Hospital of Liège, Liège, BelgiumSearch for more papers by this authorSuneeta Madan-Khetarpal, Suneeta Madan-Khetarpal Division of Medical Genetics, Department of Pediatrics, Children's Hospital of Pittsburgh, PennsylvaniaSearch for more papers by this authorFrank C. Sciurba, Frank C. Sciurba Division of Pulmonary and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PennsylvaniaSearch for more papers by this authorSofie Symoens, Sofie Symoens Center for Medical Genetics, Ghent University Hospital, Ghent, BelgiumSearch for more papers by this authorPaul J Coucke, Paul J Coucke Center for Medical Genetics, Ghent University Hospital, Ghent, BelgiumSearch for more papers by this authorLionel Van Maldergem, Lionel Van Maldergem Centre de Génétique Humaine, Université de Franche-Comté, Besançon, FranceSearch for more papers by this authorZsolt Urban, Zsolt Urban Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania These two authors contributed equally to this work.Search for more papers by this authorAnne De Paepe, Anne De Paepe Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium These two authors contributed equally to this work.Search for more papers by this author First published: 24 July 2012 https://doi.org/10.1002/humu.22165Citations: 57 Communicated by Peter H. Byers Contract grant sponsors: Methusalem grant from the Ghent University (BOF 08/01M01108 to A.D.P.); National Institutes of Health (RO1 HL090648 to Z.U., P50 HL 084948 to F.C.S., and UL1 RR024153 to the University of Pittsburgh Clinical and Translational Science Institute); Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin branch, Taiwan (to C.T.S.); Fund for Scientific Research—Flanders (postdoctoral fellowship to B.C. and F.M.); BOF research fellowship from the Ghent University (to O.V.) Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Abstract Autosomal recessive cutis laxa type I (ARCL type I) is characterized by generalized cutis laxa with pulmonary emphysema and/or vascular complications. Rarely, mutations can be identified in FBLN4 or FBLN5. Recently, LTBP4 mutations have been implicated in a similar phenotype. Studying FBLN4, FBLN5, and LTBP4 in 12 families with ARCL type I, we found bi-allelic FBLN5 mutations in two probands, whereas nine probands harbored biallelic mutations in LTBP4. FBLN5 and LTBP4 mutations cause a very similar phenotype associated with severe pulmonary emphysema, in the absence of vascular tortuosity or aneurysms. Gastrointestinal and genitourinary tract involvement seems to be more severe in patients with LTBP4 mutations. Functional studies showed that most premature termination mutations in LTBP4 result in severely reduced mRNA and protein levels. This correlated with increased transforming growth factor-beta (TGFβ) activity. However, one mutation, c.4127dupC, escaped nonsense-mediated decay. The corresponding mutant protein (p.Arg1377Alafs*27) showed reduced colocalization with fibronectin, leading to an abnormal morphology of microfibrils in fibroblast cultures, while retaining normal TGFβ activity. We conclude that LTBP4 mutations cause disease through both loss of function and gain of function mechanisms. References Abe M, Harpel JG, Metz CN, Nunes I, Loskutoff DJ, Rifkin DB. 1994. An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem 216: 276– 284. Annes JP, Chen Y, Munger JS, Rifkin DB. 2004. Integrin alphaVbeta6-mediated activation of latent TGF-beta requires the latent TGF-beta binding protein-1. J Cell Biol 165: 723– 734. Bicknell LS, Pitt J, Aftimos S, Ramadas R, Maw MA, Robertson SP. 2008. A missense mutation in ALDH18A1, encoding Delta1-pyrroline-5-carboxylate synthase (P5CS), causes an autosomal recessive neurocutaneous syndrome. Eur J Hum Genet 16: 1176– 1186. Callewaert B, Renard M, Hucthagowder V, Albrecht B, Hausser I, Blair E, Dias C, Albino A, Wachi H, Sato F, Mecham R, Loeys B, Coucke P, De Paepe A, Urban Z. 2011. New insights into the pathogenesis of autosomal-dominant cutis laxa with report of five ELN mutations. Hum Mutat 32: 445– 455. Callewaert BL, Willaert A, Kerstjens-Frederikse WS, De Backer J, Devriendt K, Albrecht B, Ramos-Arroyo MA, Doco-Fenzy M, Hennekam RC, Pyeritz RE, Krogmann O, Gillessen-Kaesbach G. 2008. Arterial tortuosity syndrome: clinical and molecular findings in 12 newly identified families. Hum Mutat 29: 150– 158. Claus S, Fischer J, Megarbane H, Megarbane A, Jobard F, Debret R, Peyrol S, Saker S, Devillers M, Sommer P, Damour O. 2008. A p.C217R mutation in fibulin-5 from cutis laxa patients is associated with incomplete extracellular matrix formation in a skin equivalent model. J Invest Dermatol 128: 1442– 1450. Dasouki M, Markova D, Garola R, Sasaki T, Charbonneau NL, Sakai LY, Chu ML. 2007. Compound heterozygous mutations in fibulin-4 causing neonatal lethal pulmonary artery occlusion, aortic aneurysm, arachnodactyly, and mild cutis laxa. Am J Med Genet A 143A: 2635– 2641. Davis EC. 1993. Stability of elastin in the developing mouse aorta: a quantitative radioautographic study. Histochemistry 100: 17– 26. de Cavanagh EM, Ferder M, Inserra F, Ferder L. 2009. Angiotensin II, mitochondria, cytoskeletal, and extracellular matrix connections: an integrating viewpoint. Am J Physiol Heart Circ Physiol 296: H550– H558. de Schepper S, Loeys B, de Paepe A, Lambert J, Naeyaert JM. 2003. Cutis laxa of the autosomal recessive type in a consanguineous family. Eur J Dermatol 13: 529– 533. Elahi E, Kalhor R, Banihosseini SS, Torabi N, Pour-Jafari H, Houshmand M, Amini SS, Ramezani A, Loeys B. 2006. Homozygous missense mutation in fibulin-5 in an Iranian autosomal recessive cutis laxa pedigree and associated haplotype. J Invest Dermatol 126: 1506– 1509. Guernsey DL, Jiang H, Evans SC, Ferguson M, Matsuoka M, Nightingale M, Rideout AL, Provost S, Bedard K, Orr A, Dube M, Ludman M, Samuels M. 2009. Mutation in pyrroline-5-carboxylate reductase 1 gene in families with cutis laxa type 2. Am J Hum Genet 85: 120– 129. Hu Q, Loeys BL, Coucke PJ, De Paepe A, Mecham RP, Choi J, Davis EC, Urban Z. 2006. Fibulin-5 mutations: mechanisms of impaired elastic fiber formation in recessive cutis laxa. Hum Mol Genet 15: 3379– 3386. Hu Q, Shifren A, Sens C, Choi J, Szabo Z, Starcher BC, Knutsen RH, Shipley JM, Davis EC, Mecham RP, Urban Z. 2010. Mechanisms of emphysema in autosomal dominant cutis laxa. Matrix Biol 29: 621– 628. Hucthagowder V, Sausgruber N, Kim KH, Angle B, Marmorstein LY, Urban Z. 2006. Fibulin-4: a novel gene for an autosomal recessive cutis laxa syndrome. Am J Hum Genet 78: 1075– 1080. Jensen SA, Iqbal S, Lowe ED, Redfield C, Handford PA. 2009. Structure and interdomain interactions of a hybrid domain: a disulphide-rich module of the fibrillin/LTBP superfamily of matrix proteins. Structure 17: 759– 768. Jobling MF, Mott JD, Finnegan MT, Jurukovski V, Erickson AC, Walian PJ, Taylor SE, Ledbetter S, Lawrence CM, Rifkin DB, Barcellos-Hoff M. 2006. Isoform-specific activation of latent transforming growth factor beta (LTGF-beta) by reactive oxygen species. Radiat Res 166: 839– 848. Kaler SG, Gallo LK, Proud VK, Percy AK, Mark Y, Segal NA, Goldstein DS, Holmes CS, Gahl WA. 1994. Occipital horn syndrome and a mild Menkes phenotype associated with splice site mutations at the MNK locus. Nat Genet 8: 195– 202. Kantola AK, Keski-Oja J, Koli K. 2008. Fibronectin and heparin binding domains of latent TGF-beta binding protein (LTBP)-4 mediate matrix targeting and cell adhesion. Exp Cell Res 314: 2488– 2500. Koli K, Myllarniemi M, Keski-Oja J, Kinnula VL. 2008. Transforming growth factor-beta activation in the lung: focus on fibrosis and reactive oxygen species. Antioxid Redox Signal 10: 333– 342. Kornak U, Reynders E, Dimopoulou A, van Reeuwijk J, Fischer B, Rajab A, Budde B, Nurnberg P, Foulquier F, Lefeber D, Urban Z, Gruenewald S. 2008. Impaired glycosylation and cutis laxa caused by mutations in the vesicular H+-ATPase subunit ATP6V0A2. Nat Genet 40: 32– 34. Krogh C, Fischer TK, Skotte L, Biggar RJ, Oyen N, Skytthe A, Goertz S, Christensen K, Wohlfahrt J, Melbye M. 2010. Familial aggregation and heritability of pyloric stenosis. JAMA 303: 2393– 2399. Lack J, O'Leary JM, Knott V, Yuan X, Rifkin DB, Handford PA, Downing AK. 2003. Solution structure of the third TB domain from LTBP1 provides insight into assembly of the large latent complex that sequesters latent TGF-beta. J Mol Biol 334: 281– 291. Leao-Teles E, Quelhas D, Vilarinho L, Jaeken J. 2009. De Barsy syndrome and ATP6V0A2-CDG. Eur J Hum Genet. Lewis KG, Bercovitch L, Dill SW, Robinson-Bostom L. 2004. Acquired disorders of elastic tissue: part II. Decreased elastic tissue. J Am Acad Dermatol 51: 165– 185, quiz 186–188. Loeys BL, Chen J, Neptune ER, Judge DP, Podowski M, Holm T, Meyers J, Leitch CC, Katsanis N, Sharifi N, Xu F, Myers L, et al. 2005. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 37: 275– 281. Loeys B, Van Maldergem L, Mortier G, Coucke P, Gerniers S, Naeyaert JM, De Paepe A. 2002. Homozygosity for a missense mutation in fibulin-5 (FBLN5) results in a severe form of cutis laxa. Hum Mol Genet 11: 2113– 2118. Markova D, Zou Y, Ringpfeil F, Sasaki T, Kostka G, Timpl R, Uitto J, Chu ML. 2003. Genetic heterogeneity of cutis laxa: a heterozygous tandem duplication within the fibulin-5 (FBLN5) gene. Am J Hum Genet 72: 998– 1004. Matsuoka S, Washko GR, Yamashiro T, Estepar RS, Diaz A, Silverman EK, Hoffman E, Fessler HE, Criner GJ, Marchetti N, Scharf S, Martinez F, Reilly J, Hatabu H. 2010. Pulmonary hypertension and computed tomography measurement of small pulmonary vessels in severe emphysema. Am J Respir Crit Care Med 181: 218– 225. Nascimento GM, Nunes CS, Menegotto PF, Raskin S, Almeida N. 2010. Cutis laxa: case report. An Bras Dermatol 85: 684– 686. Neptune ER, Frischmeyer PA, Arking DE, Myers L, Bunton TE, Gayraud B, Ramirez F, Sakai LY, Dietz HC. 2003. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet 33: 407– 411. Renard M, Holm T, Veith R, Callewaert BL, Ades LC, Baspinar O, Pickart A, Dasouki M, Hoyer J, Rauch A, Trapane P, Earing M, et al. 2010. Altered TGFbeta signaling and cardiovascular manifestations in patients with autosomal recessive cutis laxa type I caused by fibulin-4 deficiency. Eur J Hum Genet 18: 895– 901. Reversade B, Escande-Beillard N, Dimopoulou A, Fischer B, Chng SC, Li Y, Shboul M, Tham PY, Kayserili H, Al-Gazali L, Shahwan M, Brancati F, et al. 2009. Mutations in PYCR1 cause cutis laxa with progeroid features. Nat Genet. 41: 1016– 1021. Szabo Z, Crepeau MW, Mitchell AL, Stephan MJ, Puntel RA, Yin Loke K, Kirk RC, Urban Z. 2006. Aortic aneurysmal disease and cutis laxa caused by defects in the elastin gene. J Med Genet 43: 255– 258. Tassabehji M, Metcalfe K, Hurst J, Ashcroft GS, Kielty C, Wilmot C, Donnai D, Read AP, Jones CJ. 1998. An elastin gene mutation producing abnormal tropoelastin and abnormal elastic fibres in a patient with autosomal dominant cutis laxa. Hum Mol Genet 7: 1021– 1028. Urban Z, Gao J, Pope FM, Davis EC. 2005. Autosomal dominant cutis laxa with severe lung disease: synthesis and matrix deposition of mutant tropoelastin. J Invest Dermatol 124: 1193– 1199. Urban Z, Hucthagowder V, Schurmann N, Todorovic V, Zilberberg L, Choi J, Sens C, Brown CW, Clark RD, Holland KE, Marble M, Sakai L, Dabovic B, Rifkin D, Davis E. 2009. Mutations in LTBP4 cause a syndrome of impaired pulmonary, gastrointestinal, genitourinary, musculoskeletal, and dermal development. Am J Hum Genet 85: 593– 605. Van Maldergem L, Vamos E, Liebaers I, Petit P, Vandevelde G, Simonis-Blumenfrucht A, Bouffioux R, Kulakowski S, Hanquinet S, Van Durme P, et al. 1988. Severe congenital cutis laxa with pulmonary emphysema: a family with three affected sibs. Am J Med Genet 31: 455– 464. Willaert A, Khatri S, Callewaert BL, Coucke PJ, Crosby SD, Lee JG, Davis EC, Shiva S, Tsang M, De Paepe A, Urban Z. 2012. GLUT10 is required for the development of the cardiovascular system and the notochord and connects mitochondrial function to TGFbeta signaling. Hum Mol Genet 21: 1248– 1259. Wipff PJ, Hinz B. 2008. Integrins and the activation of latent transforming growth factor beta1—an intimate relationship. Eur J Cell Biol 87: 601– 615. Wipff PJ, Rifkin DB, Meister JJ, Hinz B. 2007. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol 179: 1311– 1323. Citing Literature Supporting Information Additional Supporting Information may be found in the online version of this article. Filename Description humu22165-sup-0001-FigureS1.pdf1.1 MB Supplementary Figure Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article. Volume34, Issue1January 2013Pages 111-121 ReferencesRelatedInformation

Referência(s)